Replies to post #102122 on Biotech Values

[oc631]

In general, your posts strike me as somewhat gullible with respect to VRUS’ talking points

If trusting management, and believing in the science, is being gullible I guess I'm guilty as charged. Perhaps it's your scepticism that's the issue here.

VRUS is a fine company that has a nice portfolio of HCV drugs, but they do not have anything radically different from the pyrimidine and purine nukes of other HCV companies

Do you consider a dual nuke DAA (without a third drug) radical?